Rozlytrek (entrectinib) injection is used for the treatment of patients with non-small cell lung cancer Treatment

ROZLYTREK is a kinase inhibitor indicated for the treatment of: • Adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive. (1.1) • Adult and pediatric patients 12 years of age and older with solid tumors

Rozlytrek (entrectinib) injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Rozlytrek (entrectinib) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Rozlytrek (entrectinib) injection tablets cost price in India.

The order for Rozlytrek (entrectinib) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Entrectinib (INN, trade name Rozlytrek previously known as RXDX-101 and NMS-E628) is an anti-cancer drug used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It was approved in the United States on 15 August 2019. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (Trk) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).

Rozlytrek (entrectinib) injection tablets, for oral use. Initial U.S. Approval: 2017

Generic Name: Entrectinib

Rozlytrek (entrectinib)

Rozlytrek (entrectinib) injection tablets, for oral use is available.

Get In Touch

Rozlytrek (entrectinib) injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Rozlytrek (entrectinib) injection on prescription and Import License in Patient's Name only.

For overseas patients, Rozlytrek (entrectinib) injection can be made available in Send your enquiry to find Rozlytrek (entrectinib) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Rozlytrek (entrectinib) injection.

For Rozlytrek (entrectinib) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA approves Roche’s RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours For More Details

FDA Approves Entrectinib for ROS1+ NSCLC and NTRK+ Solid Tumors For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur